The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase
Schlaepfer, D. D., Hanks, S. K., Hunter, T., & Geer, P. V. D. (1994) · Nature · doi:10.1038/372786a0 · Cited by 1,595 · cited 1×
“The reduction in FAK Y861 and Y925 phosphorylation have been previously shown to disrupt b5-integrin association and SH2-mediated Grb2 adaptor protein binding, respectively (Schlaepfer et al., 1994; Eliceiri et al., 2002).”
BackgroundSelf-citationWeaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483 · cited 1×
“Antibody-mediated blockage (Weaver et al., 1997), dominant-negative inhibition (De et al., 2005), or genetic inactivation (White et al., 2004) of integrins prevents tumor progression.”
BackgroundIlić, D., Almeida, E. A. C., Schlaepfer, D. D., Dazin, P., Aizawa, S., & Damsky, C. H. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.547 · Cited by 495
Self-citationWhite, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413 · cited 3×
“As integrin-linked kinase can promote tumor growth (Tan et al., 2004) and b1-integrin expression is critical for mammary tumorigenesis in vivo (White et al., 2004), it is important to determine the linkage of a b1-integrin-activated protein-tyrosine kinase (PTK) such as focal adhesion kinase (FAK)…”
Background
Cited by
Integrin-regulated FAK–Src signaling in normal and cancer cells
Mitra, S. K., & Schlaepfer, D. D. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.011 · Cited by 1,590
Self-citationFAK in cancer: mechanistic findings and clinical applications
Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381
Self-citationFocal adhesion kinase and its signaling pathways in cell migration and angiogenesis
Zhao, X., & Guan, J.-L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.001 · Cited by 835
Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
Lim, S.-T., Chen, X. L., Lim, Y., Hanson, D. A., Vo, T.-T., Howerton, K., Larocque, N., Fisher, S. J., Schlaepfer, D. D., & Ilic, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.031 · Cited by 480
Self-citationFAK signaling in human cancer as a target for therapeutics
Lee, B. Y., Timpson, P., Horvath, L. G., & Daly, R. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.001 · Cited by 425
Metadata
- Authors
- Mitra, S. K., Mikolon, D., Molina, J. E., Hsia, D. A., Hanson, D. A., Chi, A., Lim, S.-T., Bernard-Trifilo, J. A., Ilic, D., Stupack, D. G., Cheresh, D. A., & Schlaepfer, D. D.
- Venue
- Oncogene
- Published
- 2006-05-08
- Volume
- 25
- Issue
- 44
- Pages
- 5969-5984
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1970131417
- Cited by
- 158
- References
- 6
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.